Drug Combination Details
General Information of the Combination (ID: C12652) | |||||
---|---|---|---|---|---|
Name | Apicidin NP Info | + | Imatinib Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Acute lymphoblastic leukemia
[ICD-11: 2B33]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | ABL | Molecule Info |
Pathway MAP
|
|
In-vitro Model | K-562 | CVCL_0004 | Chronic myelogenous leukemia | Homo sapiens | ||
Experimental
Result(s) |
Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades. |
